
Validea's guru fundamental report identifies Becton Dickinson (BDX), a large-cap medical equipment and supplies company, as its highest-rated stock under the Peter Lynch P/E/Growth Investor model. However, BDX received a 54% rating based on its fundamentals and valuation, falling short of the 80% threshold typically indicating 'some interest.' The stock passed tests for P/E/Growth ratio, inventory to sales, and total debt/equity, but failed on sales and P/E ratio and EPS growth rate, suggesting a mixed fundamental outlook despite its top ranking within this specific model.
According to Validea's fundamental report, Becton Dickinson and Co. (BDX) presents a mixed profile under the Peter Lynch investment model. While it ranks as the highest-rated stock using this specific P/E/Growth strategy, its overall score is a tepid 54%, falling significantly short of the 80% threshold that typically indicates guru interest. The analysis reveals specific strengths in its financial structure and operational efficiency, as evidenced by passing grades on its Total Debt/Equity ratio and Inventory to Sales metric. Furthermore, its P/E/Growth ratio is deemed reasonable. However, these positives are offset by critical failures in core growth areas; BDX did not pass the criteria for EPS Growth Rate or the Sales and P/E Ratio. Additionally, its ratings for Free Cash Flow and Net Cash Position are merely neutral, suggesting a lack of compelling strength in liquidity and cash generation. This combination indicates that despite a strong balance sheet, the company's growth trajectory and valuation relative to sales are not aligned with the key tenets of the Lynch strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment